Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
July 08, 2022 at 16:14 PM EDT
Virpax is once again taking the OTC route for a new product candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.